This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Lars Nygaard: Innovator in Pharmaceutical Composition
Introduction
Lars Nygaard is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work involving tiagabine hydrochloride. His expertise and dedication have led to the development of a patent that enhances the understanding and application of this important compound.
Latest Patents
Lars holds a patent for a pharmaceutical composition containing tiagabine hydrochloride. This invention is crucial for advancing treatment options in various medical conditions, showcasing his commitment to improving healthcare through innovation. He has 1 patent to his name, reflecting his focused contributions to the industry.
Career Highlights
Lars Nygaard is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to work at the forefront of pharmaceutical research and development. His career is marked by a dedication to creating effective solutions that address pressing health issues.
Collaborations
Throughout his career, Lars has collaborated with talented professionals, including Jo Slashedrgen Svensson and Helle Weibel. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their projects.
Conclusion
Lars Nygaard is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact in the field. His patent for tiagabine hydrochloride exemplifies his innovative spirit and commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
